Curetis specializes in the development and marketing of molecular diagnostic systems for hospitals and laboratories. The products are devoted to detecting severe infectious diseases as well as resistance to anti-biotics in hospitalized patients. The diagnostic solutions (Unyvero Solution) enable rapid multi-parameter pathogen and antibiotic resistance detection in only a few hours, a process that today can take up to days or even weeks with other techniques. Syndromic tests for diagnosing lower respiratory tract infections /pneumonia as well as implant and tissue infections are commercially available.
More about the company